Amarin Corp Plc (AMRN)

[Whalatane]

Hi Gabor re Fig 3

Figure 3

Cardiac mortality with or without statins. Kaplan-Meier analysis for cardiac mortality (A) without statins (n = 343) and (B) with statins (n = 234). Cardiac mortality was significantly higher in the low-EPA/AA group than in the high-EPA/AA group in HF patients with statins (P = 0.003), but not in HF patients without statins (P = 0.193).

The biggest separation between the event lines of low-EPA/AA vs high EPA/AA was when the patients were also on statin therapy.
At least thats how the graphs look to me .
Am I reading that wrong ?
Yes agree ...statins boost the EPA benefit
Kiwi